|
Market Closed -
Australian S.E.
09:10:11 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4500 AUD | +4.65% |
|
-4.26% | +25.00% |
| 10-23 | Starpharma Holdings Limited Announces Change of Address | CI |
| 10-20 | Starpharma Lifts Stake in Petalion Therapeutics to 66%, Gains Majority Control of Oncology Program | MT |
| Market Cap | 216M 152M 136M 125M 113M 212M 14.42B 1.49B 599M 7.59B 570M 558M 23.92B | P/E 2027 * |
-15x | P/E 2028 * | 100x |
|---|---|---|---|---|---|
| Enterprise Value | 189M 133M 119M 109M 99.06M 185M 12.6B 1.3B 523M 6.63B 498M 487M 20.9B | EV / Sales 2027 * |
29.9x | EV / Sales 2028 * | 6.76x |
| Free-Float |
69.55% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| SPL | Delayed | |
OTC Markets
| SPHRF | Delayed | |
|
Deutsche Boerse AG
| PQ6 | Delayed | |
|
Börse Stuttgart
| PQ6 | Delayed | |
|
Boerse Muenchen
| PQ6 | Real-time | |
|
Berne S.E.
| PQ6 | End-of-day quote |
| 1 day | +4.65% | ||
| 1 week | -4.26% | ||
| Current month | -48.28% | ||
| 1 month | -46.11% | ||
| 3 months | -39.19% | ||
| 6 months | -37.50% | ||
| Current year | +25.00% |
| 1 week | 0.42 |  | 0.49 |
| 1 month | 0.42 | | 0.87 |
| Current year | 0.33 | | 0.88 |
| 1 year | 0.32 | | 0.88 |
| 3 years | 0.08 | | 0.88 |
| 5 years | 0.08 | | 1.38 |
| 10 years | 0.08 | | 2.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 08/01/2024 |
Justin Cahill
DFI | Director of Finance/CFO | - | 03/04/2023 |
Jeremy Paull
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Thomas
CHM | Chairman | 81 | 13/06/2014 |
David McIntyre
BRD | Director/Board Member | 55 | 01/03/2020 |
Lynda Cheng
BRD | Director/Board Member | - | 01/08/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Expiration | Chief Executive Officer | -702,768 | 0.1473% | ||
| 11/08/26 | Buy | Chairman | 350,001 | 0.0734% | ||
| 11/08/26 | Buy | Director | 22,741 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.65% | -4.26% | +23.29% | +221.43% | 145M | |
| +3.03% | +11.21% | +67.70% | +150.35% | 1,224B | |
| -0.36% | +4.04% | +45.19% | +86.68% | 662B | |
| +1.16% | +2.96% | +28.88% | +107.27% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.20% | +3.04% | +73.48% | +45.77% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.12% | +6.15% | +59.68% | +77.16% | 249B | |
| +3.46% | +9.56% | +44.33% | +119.81% | 205B | |
| Average | +2.39% | +1.48% | +44.33% | +97.04% | 417.7B | |
| Weighted average by Cap. | +1.96% | +3.04% | +50.96% | +98.27% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 6.3M 4.43M 3.97M 3.65M 3.31M 6.18M 421M 43.54M 17.48M 221M 16.63M 16.28M 698M | 26.25M 18.47M 16.54M 15.21M 13.79M 25.77M 1.75B 181M 72.83M 922M 69.31M 67.83M 2.91B |
| Net income | -16.25M -11.43M -10.24M -9.42M -8.53M -15.95M -1.09B -112M -45.09M -571M -42.91M -42M -1.8B | 1.71M 1.2M 1.08M 989K 897K 1.68M 114M 11.8M 4.74M 59.99M 4.51M 4.41M 189M |
| Net Debt | -27.25M -19.17M -17.17M -15.8M -14.31M -26.75M -1.82B -188M -75.62M -958M -71.96M -70.43M -3.02B | -38.53M -27.11M -24.28M -22.33M -20.23M -37.82M -2.57B -266M -107M -1.35B -102M -99.57M -4.27B |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | A$0.4500 | +4.65% | 1,693,181 |
| 29/10/26 | A$0.4300 | -6.52% | 1,186,114 |
| 28/10/26 | A$0.4600 | +3.37% | 850,991 |
| 27/10/26 | A$0.4450 | -6.32% | 1,587,068 |
| 26/10/26 | A$0.4750 | +2.15% | 2,070,086 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4500AUD
Average target price
1.220AUD
Spread / Average Target
+171.11%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
